These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 19425326
1. [The treatment of hepatocellular carcinoma. New developments]. Kuiken SD, van Delden OM, Richel DJ, Jansen PL. Ned Tijdschr Geneeskd; 2009 Apr 04; 153(14):668-72. PubMed ID: 19425326 [No Abstract] [Full Text] [Related]
2. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach. Bathaix F, Marion D, Cuinet M, Maillard E, Zoulim F, Mornex F, Merle P. Gastroenterol Clin Biol; 2010 Apr 04; 34(4-5):314-8. PubMed ID: 20207091 [Abstract] [Full Text] [Related]
3. Closing remarks. Kudo M. Clin Drug Investig; 2012 Aug 08; 32 Suppl 2():52. PubMed ID: 22873627 [No Abstract] [Full Text] [Related]
4. Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma. Sinakos E, Dedes I, Papalavrentios L, Drevelegas A, Akriviadis E. Scand J Gastroenterol; 2010 Apr 08; 45(4):511-2. PubMed ID: 20113152 [No Abstract] [Full Text] [Related]
5. [Hepatocellular carcinoma: what's new?]. Teufel A, Marquardt JU, Galle PR, Wörns M. Dtsch Med Wochenschr; 2012 Feb 08; 137(5):210-3. PubMed ID: 22250042 [No Abstract] [Full Text] [Related]
11. TACE with or without systemic therapy? Dufour JF. J Hepatol; 2012 Jun 08; 56(6):1224-5. PubMed ID: 22402292 [No Abstract] [Full Text] [Related]
12. Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization". Park JW, Kim HB, Lee IJ. J Hepatol; 2013 Jan 08; 58(1):195. PubMed ID: 23046675 [No Abstract] [Full Text] [Related]
13. [Prospect of hepatocellular carcinoma in 2008]. Ye SL. Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 08; 17(1):7-9. PubMed ID: 19391280 [No Abstract] [Full Text] [Related]
14. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. O'Neil BH, Venook AP. Oncologist; 2007 Dec 08; 12(12):1425-32. PubMed ID: 18165619 [Abstract] [Full Text] [Related]
15. Treatment of hepatocellular carcinoma. Giuliani F, Colucci G. Oncology; 2009 Dec 08; 77 Suppl 1():43-9. PubMed ID: 20130431 [Abstract] [Full Text] [Related]
16. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy. Plentz RR, Lankisch TO, Bastürk M, Müller CC, Kirchhoff T, Gebel M, Bleck JS, Kubicka S, Manns MP, Meier PN, Rudolph KL. J Gastroenterol Hepatol; 2005 Jul 08; 20(7):1134-6. PubMed ID: 15955232 [No Abstract] [Full Text] [Related]
17. Transarterial chemoembolization for hepatocellular carcinoma. Lau WY, Yu SC, Lai EC, Leung TW. J Am Coll Surg; 2006 Jan 08; 202(1):155-68. PubMed ID: 16377509 [No Abstract] [Full Text] [Related]
18. The chance of further chemoembolization and intrahepatic disease control after radiotherapy to portal vein thrombus. Cheng JC. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1316. PubMed ID: 15001277 [No Abstract] [Full Text] [Related]
19. [Approaches for interventional therapy of hepatoma]. Guan YS, Yang L. Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 15; 13(10):785. PubMed ID: 16248956 [No Abstract] [Full Text] [Related]